Last year, the LuMind RDS Board of Directors agreed that a new vision — to be a global leader in funding a comprehensive portfolio of research to meaningfully improve memory, cognition, and independence in individuals with Down syndrome — will guide the next decade of growth and innovation. That growth began at the top with the addition of two new board members whose background and experience will help LuMind RDS realize that vision. Both are committed to making this vision a reality by continuously pushing the boundaries of cognitive research and delivering much-needed resources to the most innovative and committed professionals in the field. Like us, they believe cognition and research empower success and we are so excited to welcome them to the board of directors!
Bjoern Sperling, MD
Sr. Director, Clinical Development, Alzheimer’s Disease
Bjoern Sperling brings a great deal of personal and professional experience with Down syndrome and Alzheimer’s disease to the LuMind RDS board. Bjorn began giving back to his community as a volunteer coach for individuals with physical disabilities, including some Paralympic athletes. Now, he is leveraging years of experience as a medical director in clinics and biopharmaceuticals to contribute to organizations that are advancing research to improve cognition in individuals with Down syndrome and delay the early-onset of Alzheimer’s disease.
Before becoming the senior medical director of clinical development for Alzheimer’s disease with Biogen, Bjoern spent many years in medical affairs as the global therapeutic lead for Multiple sclerosis. He has previously authored or co-authored more than 30 papers and presented multiple abstracts at scientific congresses including as an invited speaker, and has given educational presentations at universities worldwide.
Bjoern also brings great insight about the opportunities research can have on emerging adults with Down syndrome from his own 22-year-old son, Sebastian. “Sebastian has a beautiful mind, always curious, interested and eager to study new things, he brings a lot of insights and joy into our lives, and I want to do my best to protect his and others minds from the devastating effect of Alzheimer’s disease. My hope is that I through LuMind can support the research and work that is so much needed to improve and preserve the quality of life of people with Ds,” says Bjoern. Bjoern and his family moved from Denmark 6 years ago and now live in Massachusetts.
Technology Investor at Hg Capital
From all the way across the “pond” in the UK, we also welcome Hector Guinness to the LuMind
RDS board. Hector was introduced to us last year when he ran the NYC Marathon, raising over $68.000 for LuMind RDS. After finishing the marathon with an official time of 4:41.33, he continued to express his interest in helping LuMind gain support overseas for the research we fund. Hector will focus on helping raise money and awareness for Down Syndrome research in the UK.
Like with other LuMind RDS board members, we are in awe of how he balances a busy work and family life with significant philanthropic activities. Since 2012, Hector Guinness has been with HgCapital, where he focuses on investments in growing technology companies, and represents Hg as a board observer at Allocate Software, Evaluate and TraceOne. Prior to joining HgCapital, Hector spent three years working at Bain & Company in London and Mumbai.
Hector graduated from the University of Oxford with a first class honours degree in Biological Science. He and his wife, Lucy Guinness are the proud parents of Alfred and a new baby girl, Jemima.